Navamedic ASA: Renewed contract for delivering antibiotics to Norwegian hospitals Published: 16.05.2024 Navamedic welcomes new shareholders Published: 13.03.2024 Navamedic ASA launches Eroxon® Published: 12.02.2024 Navamedic ASA acquires innovative antibiotic product for hospital use in the Nordic region Published: 23.11.2022 Navamedic ASA launches ForlaxGO® – an innovative on-the-go product for the treatment of constipation Published: 20.10.2022 Navamedic ASA – Exclusive agreement with Vectans Pharma for the unique cold sore treatment product Sitavig® Published: 04.08.2022 FirstPrevious1234NextLast
Navamedic ASA: Renewed contract for delivering antibiotics to Norwegian hospitals Published: 16.05.2024
Navamedic ASA acquires innovative antibiotic product for hospital use in the Nordic region Published: 23.11.2022
Navamedic ASA launches ForlaxGO® – an innovative on-the-go product for the treatment of constipation Published: 20.10.2022
Navamedic ASA – Exclusive agreement with Vectans Pharma for the unique cold sore treatment product Sitavig® Published: 04.08.2022